Dr. Sanjay Mahajan

·         Graduate of Calcutta & has done Post Graduation in Internal Medicine from Mumbai.

·         He has more than 25years of profound experience of Medicine & Intensive Care in various reputed institutions of the country.

·         Former visiting consultant to Jaslok hospital, Mumbai & Batra Hospital, Delhi

·         Presently in the core committee & was past Treasurer to API-UP CHAPTER.

·         Actively involved in Academics as Speaker/Chairperson in various National & International Congregation

·         Actively participated in the Management of HIV/AIDS patients, including post mortem study - Sir J.J. Group of Hospitals, Mumbai in 

        collaboration with ARCON (Aids Research Control Programme) - Texas University.

• Research Society for the Study of Diabetes in India (RSSDI)
• Indian Medical Association-East Delhi Branch(IMA EDB)
• National Academy of Medical Sciences, Delhi - (MNAMS)
• The Association of Physicians of India (API)
• Indian Society of Critical Care Medicine (ISCCM)
• He is also a Member of Infection Control Committee, Kailash Hospital , Noida

Fellowship

• Fellow of Diabetes India
• Fellow of The American College of Physicians, USA (FACP)
• Fellow of The Royal College of Physicians, (Glasgow, UK) (FRCP)
• Fellow of International College of Nutrition (FICN)

1.       Conferred with various National Awards for his meritorious service to the medical profession.

• RAJIV GANDHI EXCELLENCE AWARD -2011
• HEALTH LEADERSHIP AWARD-2016
• RAJIV GANDHI LIFETIME ACHIEVEMENT AWARD-2016
• BHARAT GAURAV SAMMAAN -2017
• AROGYA RATAN AWARDS - 2018

2.       Recipient of the Medal of Excellence & Appreciation by Jaslok Hospital & Research Centre, Mumbai under the aegis of the Bombay Heart Brigade (a Community service project of the Rotary Club of Mumbai).

• Singh RB, Chuchalin AG, Shogenova L, Kuropatkina TK, Medvedev O, Hasan I, Fatima G, Mahajan S. Yogurt and the heart. World Heart J 2023; 14 (4): in press
• Elkilany G, Fedacko J, Sozzi F, Mahajan S, Slezak J. Cardiac Resynchronization Therapy in Chronic Heart Failure. World Heart J 2014 (4): in press
• Singh RB, Fedacko J, Smail MA, Elkilany G, Mahajan S. Vulnerable Atherosclerotic Plaque is the Target for Prevention of Cardiovascular Events and Deaths? World Heart J 2024; 15 (1): in press

Poster presentation

• 2024 Diabetes Canada/CSEM Professional Conference and Annual Meetings that took place on November 20–23, 2024 at the Halifax Convention Centre,Halifax,NOVA SCOTIA,CANADA. (Diabetes Canada /Canadian Society of Endocrinology & Metabolism) TOPIC: “Effectiveness and Safety of a Single Pill combination of Empagliflozin/Linagliptin”

• His special area of interest are Diabetes, Infection Control, Chest diseases & Critical Care.